Gf Fermentech / 지에프퍼멘텍 Revenue

Biotechnology Research • 74-12 Geumhoseonmal-gil, Bugang, Korea, Republic of • 21-50 Employees

Gf Fermentech / 지에프퍼멘텍 revenue & valuation

Annual revenue	$2,309,985
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$7,400,000
Total funding	No funding

Key Contacts at Gf Fermentech / 지에프퍼멘텍

Jeong Jun Han

Chief Executive Officer

Dong-Eun Chang

Chief Technology Officer

Phil Yong Kim

Director

Company overview

Headquarters	74-12 Geumhoseonmal-gil, Bugang, Sejong, KR
Phone number	+82442775551
Websites	gffermentech.com genofocus.com
NAICS	541714
Founded	2000
Employees	21-50
Socials

Gf Fermentech / 지에프퍼멘텍 Email Formats

Gf Fermentech / 지에프퍼멘텍 uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@gffermentech.com), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@gffermentech.com	100%

About Gf Fermentech / 지에프퍼멘텍

GF Fermentech produces bioactive materials with core technologies based on strain development, fermentation, biotransformation, purification, and formulation. Over the past 20 years, we have been developing the best performing microbial strains and highly specialized extraction, purification, and formulation technologies, and we have been supplying the best-in-class bioactive materials such as Vitamin K2 MK7, Nattokinase, Lactobionic acid and phytoshingosine. GF Fermentech has dived into synthetic biology field for industrial production of renewable and sustainable bio-products. GF Fermentech holds several platform hosts for strain development, each with its own proprietary genetic set of tools and fermentation techniques for biochemicals such as retinol, phytoene, specialty proteinases etc which are produced usually by chemical synthesis or exists a little in nature. Each optimized strain can be utilized for the production of specific biochemical materials at the highest efficiency. GF Fermentech is continually expanding platform microbes In addition to strain development, as a vertically integrated biotech company, we can rapidly scale-up our strains which will be the best at what they do to produce target bioactive materials to tens of tons scale at the highest level of quality. GF Fermentech will continue to expand our business portfolio through distinct strain discovery and improvement, fermentation, purification, and formulation technology. Email: gftinfo@genofocus.com

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

Gf Fermentech / 지에프퍼멘텍 has 6 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Gf Fermentech / 지에프퍼멘텍's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-01-01	1	N/A

Funding Insights

Number of funding rounds

Gf Fermentech / 지에프퍼멘텍 Tech Stack

Discover the technologies and tools that power Gf Fermentech / 지에프퍼멘텍's digital infrastructure, from frameworks to analytics platforms.

Sectigo

SSL/TLS certificate authorities

Nginx

Reverse proxies

Microsoft 365

Frequently asked questions

Gf Fermentech / 지에프퍼멘텍 is located in 74-12 Geumhoseonmal-gil, Bugang, KR.

You can reach Gf Fermentech / 지에프퍼멘텍 at +82442775551.

Gf Fermentech / 지에프퍼멘텍 generates an estimated annual revenue of $2,309,985. This revenue figure reflects the company's market position and business performance in its industry.

Gf Fermentech / 지에프퍼멘텍 has an estimated valuation of $7,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Gf Fermentech / 지에프퍼멘텍 was founded in 2000, making it 26 years old. The company has established itself as a significant player in its industry over this time.

Gf Fermentech / 지에프퍼멘텍 has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.